Michael Schmertzler, Director at PTC THERAPEUTICS, INC. (PTCT), sold 25,000 shares at $72.74 ($1.8M) on 2026-08-26, disclosed to the SEC on 2026-08-28.
Scheduled sale ($1.8M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $72.74 | 6,874 | $500K | 27.7% |
| 2 | $73.18 | 5,626 | $412K | 22.8% |
| 3 | $71.55 | 11,890 | $851K | 47.1% |
| 4 | $72.22 | 610 | $44K | 2.4% |
| Total | $72.26 avg | 25,000 | $1.8M | 100% |
| Filing → |
| PTCT | SELL | 2026-08-21 | $1.8M | — | Filing → |
| PTCT | SELL | 2024-01-10 | $42K | — | Filing → |
| PTCT | SELL | 2023-06-09 | $45K | — | Filing → |